Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

1.72 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -69.676-82.442-91.169-125.596-67.254-35.258-8.931-4.602
Depreciation & Amortization 0.3430.4370.5080.2050.0520.0470.0440.024
Deferred Income Tax 0002.1791.725000.412
Stock Based Compensation 10.6279.60412.19714.0377.7653.6430.0640.005
Change In Working Capital -2.6923.686-9.9017.025.0420.4630.3541.744
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables 1.6830.597-2.231.5691.0691.4540.264-0.059
Other Working Capital -4.3753.089-7.6715.4513.973-0.9910.091.803
Other Non Cash Items -0.9051.9983.2832.0070.5246.4310.0150.066
Operating Cash Flow -62.303-66.717-85.082-100.148-52.146-24.674-8.454-2.351
Investing Activities:
Investments In Property Plant And Equipment 0-0.033-0.192-2.71-0.142-0.021-0.076-0.077
Acquisitions Net 000.0092.70.118000
Purchases Of Investments -122.876-61.887-60.141-49.508-372.477000
Sales Maturities Of Investments 139.7578.171113.69182.83190.928000
Other Investing Activites 0.0940.0950.054-2.7-0.118-0.02100
Investing Cash Flow 16.96816.34653.366130.613-281.691-0.021-0.076-0.077
Financing Activities:
Debt Repayment 0000000-0.05
Common Stock Issued 24.49471.850.1770.729213.844129.49952.3120.1
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 1.0530.1640.1770.7291.1127.75652.31219.948
Financing Cash Flow 25.54771.9320.1770.729214.944127.75652.3129.974
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash -19.78821.561-31.53931.194-118.893103.06143.7827.546
Cash At End Of Period 37.25657.04435.48367.02235.828154.72151.667.878